Skip to main content
Figure 4 | BMC Musculoskeletal Disorders

Figure 4

From: Lipopolysaccharide treatment suppresses spontaneously developing ankylosing enthesopathy in B10.BR male mice: The potential role of interleukin-10

Figure 4

FACS analysis of leukocyte subpopulations in the spleens of LPS-treated and control LPS-untreated B10.BR males. After the second LPS dose the percentage of macrophages (CD11b+), dendritic cells (CD11c+) and neutrophils (Ly-6G+) was increased in LPS-treated males (A) and the increase of CD11b + and Ly-6G+ cells lasted after the fourth LPS dose (B). No significant differences in the percentage of CD11b+, CD11c + and Ly-G6+ cells were found between both groups 20–22 weeks after the fourth LPS dose (C). * p < 0.05, ** p < 0.01.

Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us